Chen-Hua Chuang
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer-related gene regulation, Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation, Chemical Reactions and Isotopes
Most-Cited Works
- → Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing(2015)274 cited
- → MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans(2012)259 cited
- → An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer(2017)186 cited
- → A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo(2017)163 cited
- → An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency(2016)114 cited
- → Incremental Genetic Perturbations to MCM2-7 Expression and Subcellular Distribution Reveal Exquisite Sensitivity of Mice to DNA Replication Stress(2010)90 cited
- → Female-biased embryonic death from inflammation induced by genomic instability(2019)78 cited
- → miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts(2021)69 cited
- → Axon-like protrusions promote small cell lung cancer migration and metastasis(2019)66 cited
- → AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers(2024)56 cited